Shareholders' Equity

3 Months Ended

Dec. 28, 2024

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders' Equity

On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The program was completed in fiscal 2024. During the three months ended December 30, 2023, the Company repurchased no shares under this program.

On January 16, 2024, the Company announced a share repurchase program authorized by the Board of Directors under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2024 Program"). The 2024 Program commenced upon completion of the 2023 Program and was completed in fiscal 2024.

On August 14, 2024, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2025 Program"). The 2025 Program became effective upon completion of the 2024 Program and has no expiration. During the three months ended December 28, 2024, the Company repurchased 84,823 shares under this program for $12.8 million at an average price of $151.19 per share. As of December 28, 2024, $37.2 million of authority remained under the 2025 Program.

All shares repurchased under the aforementioned programs were recorded as treasury stock.